AKT1 and prostate carcinoma: The activation of CXCL12 chemokine has been reported to increase the motility of LNCaP and PC3 cells [81] and induction of downstream pathways such as Akt-1 and metalloproteinases, which is involved in the regulation of prostate cancer cell migration [82].